RGT-264

· Regor Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGT-264, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors [Phase 1]